Breaking News: Cannabis Life Sciences Discusses the Benefits of Medical Marijuana | Financial Buzz

Breaking News: Cannabis Life Sciences Discusses the Benefits of Medical Marijuana

CLS Holdings USA, Inc. (OTCQB: CLSH) (CLS Holdings, Inc.)also known as Cannabis Life Sciences, does not want to lose sight of how its product can ultimately help people as they expand their market share. Jeffrey Binder, Chairman and Chief Executive Officer of CLS, tells Stock Day’s Everett Jolly there are many opportunities on the horizon.

“There are a lot of applications for [medical marijuana] where it can be beneficial,” says Binder. He then pointed to the example of Colorado where medical marijuana has been used successfully for years. “People are actually flocking to the state,” he explained.

He and Jolly discussed the stats that indicate opioid addiction, in states with medical marijuana, are actually down. On a more personal note, Binder also highlighted other medical uses. 

“One of the reason’s I’m in this business is because my Godchild was diagnosed autistic. With early intervention and a dietary supplement, she has mainstreamed in school. She’ll be 8-years-old.” He added, “I don’t want us in the industry to lose sight of the benefits of medical marijuana.”

Jolly then turned to CLS’s recent letters of intent towards two businesses in Massachusetts; indications they are looking to expand. 

“We looked to Massachusetts where there are only 39 medical licenses,” explained Binder. “We believe that there will be a very limited number offered by the state. So, we see that as a great opportunity to garner market share.”

Binder told Jolly that CLS has agreed in principle to loan $5 million to In Good Health, a licensed medical dispensary in Brockton. Along with the loan, CLS will have an option to acquire In Good Health. Also, CLS has also agreed in principle to form an 80/20 joint venture with CannAssist, which CLS will own 80%. CannAssist plans to build out a recreationally licensed cultivation grow facility in Leicester.

 To hear more about CLS’ future plans, listen to the podcast here:

Sponsored Content Release. Click for Full Disclosure

  • Sponsored Content Release, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For cls holdings usa inc. financial and corporate news dissemination, has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: